Redmond Asset Management’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-37,270
| Closed | -$119K | – | 209 |
|
|
2024
Q4 | $119K | Sell |
37,270
-1,650
| -4% | -$5.26K | 0.03% | 201 |
|
|
2024
Q3 | $143K | Sell |
38,920
-715
| -2% | -$2.62K | 0.04% | 150 |
|
|
2024
Q2 | $185K | Sell |
39,635
-827
| -2% | -$3.86K | 0.06% | 151 |
|
|
2024
Q1 | $356K | Sell |
40,462
-200
| -0.5% | -$1.76K | 0.11% | 132 |
|
|
2023
Q4 | $174K | Sell |
40,662
-5,844
| -13% | -$25K | 0.06% | 154 |
|
|
2023
Q3 | $159K | Sell |
46,506
-98
| -0.2% | -$334 | 0.06% | 156 |
|
|
2023
Q2 | $263K | Sell |
46,604
-2,585
| -5% | -$14.6K | 0.09% | 147 |
|
|
2023
Q1 | $238K | Sell |
49,189
-1,184
| -2% | -$5.72K | 0.08% | 151 |
|
|
2022
Q4 | $304K | Buy |
50,373
+871
| +2% | +$5.26K | 0.11% | 146 |
|
|
2022
Q3 | $237K | Sell |
49,502
-162
| -0.3% | -$776 | 0.09% | 155 |
|
|
2022
Q2 | $284K | Sell |
49,664
-129
| -0.3% | -$738 | 0.1% | 160 |
|
|
2022
Q1 | $356K | Buy |
49,793
+606
| +1% | +$4.33K | 0.11% | 162 |
|
|
2021
Q4 | $393K | Buy |
49,187
+1,745
| +4% | +$13.9K | 0.11% | 167 |
|
|
2021
Q3 | $530K | Buy |
47,442
+1,942
| +4% | +$21.7K | 0.17% | 147 |
|
|
2021
Q2 | $664K | Buy |
45,500
+509
| +1% | +$7.43K | 0.19% | 141 |
|
|
2021
Q1 | $816K | Buy |
+44,991
| New | +$816K | 0.25% | 127 |
|